Achieve Life Sciences ACHV
NASDAQ ACHV
$7.53 -0.56 (-6.92%)
At close: Oct 1, 2026 · 4:00 PM EDT

Achieve Life Sciences (ACHV) Liabilities and Shareholders Equity (2010 - 2026)

Updated

Achieve Life Sciences' Liabilities and Shareholders Equity came in at $190.44 million for Q2 2026, up 223.1% from $58.94 million a year earlier and up 475.3% from the prior quarter.

Analysis

Achieve Life Sciences (ACHV) Liabilities and Shareholders Equity (2010 - 2026) Analysis & Trends

At the end of FY2025, Achieve Life Sciences' Liabilities and Shareholders Equity was $41.79 million, up 8.2% from FY2024.

  • Liabilities and Shareholders Equity carries a five-year compound annual growth rate of 0.7% (FY2020 to FY2025).
  • Going back by year, Liabilities and Shareholders Equity was $38.63 million in FY2024 (+99.4%), $19.37 million in FY2023 (-35.4%), $29.97 million in FY2022 (-36.9%) and $47.52 million in FY2021 (+17.9%).
  • The Q2 2026 figure represents the highest quarterly Liabilities and Shareholders Equity in data going back to Q4 2010.
  • Year-over-year, Liabilities and Shareholders Equity has increased for four consecutive quarters, with growth averaging 48.4% over the last eight quarters.
  • The fastest year-over-year change in Liabilities and Shareholders Equity over five years came in Q1 2024 (growth of 236.7%), and the weakest in Q1 2025 (a decline of 60.9%).
  • Business Quant data shows ACHV's Liabilities and Shareholders Equity at $33.11 million (Q1 2026), $41.79 million (Q4 2025) and $52.04 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 201.06 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 135.12 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 129.80 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 122.03 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 115.83 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 95.64 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 49.36 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 201.13 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 27.42 Bn
10 Achieve Life Sciences 352.68 Mn 352.68 Mn - 190.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 190.44 Mn
Mar 31, 2026 33.11 Mn
Dec 31, 2025 41.79 Mn
Sep 30, 2025 52.04 Mn
Jun 30, 2025 58.94 Mn
Mar 31, 2025 27.36 Mn
Dec 31, 2024 38.63 Mn
Sep 30, 2024 47.92 Mn
Jun 30, 2024 64.79 Mn
Mar 31, 2024 70.03 Mn
Dec 31, 2023 19.37 Mn
Sep 30, 2023 24.34 Mn
Jun 30, 2023 28.92 Mn
Mar 31, 2023 20.80 Mn
Dec 31, 2022 29.97 Mn
Sep 30, 2022 23.72 Mn
Jun 30, 2022 33.99 Mn
Mar 31, 2022 40.61 Mn
Dec 31, 2021 47.52 Mn
Sep 30, 2021 37.80 Mn
API Access

Achieve Life Sciences Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=ACHV&period=max&api_key=YOUR_API_KEY